Can a vaccine stop Antibiotic-Resistant gonorrhea?
⭐️ VACCINE ⭐️
Recruiting now
This first-in-human trial tests an experimental vaccine called LTB-NG6, designed to protect against gonorrhea. The study will enroll healthy adults aged 18-50 to evaluate the vaccine's safety and its ability to trigger an immune response. Participants will receive either the vacc…
Phase: PHASE1 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 13, 2026 00:00 UTC